ARTICLE | Clinical News
Agile begins Phase II
May 17, 2001 7:00 AM UTC
Agile Therapeutics (West Conshohocken, Penn.) began two Phase II trials of its 7-day transdermal contraceptive patch, which contains levonorgestrel (LNG) and ethinyl estradiol (EE). The trials will de...